Very excited and proud to be part of this project with Alex Wiles Mike Neuss and Robert Dunn. Many thanks to all the residents, fellows and faculty who contributed.

Congratulations to three of our fellows on acceptance into the prestigious AACR/ASCO "Vail" Workshop! 👏Ronan Hsieh (2nd year fellow) 👏 Emily Geramita (2nd year fellow) 👏 Aseel Alsouqi (1st year fellow) We are so proud of you! 🥳🎉🥂 #MedEd #pitthemeonc

Day 4 AACR ASCO #Vail workshop - a thought provoking lecture by Dr. Ruth O'Regan. Less than 10% of pts enroll in clinical trials, a critical need to rethink eligibility criteria (why are we excluding X?) and innovative ways to improve enrollment

The paper from Aseel is published! onlinelibrary.wiley.com/doi/10.1111/bj… It confirms the initial 2009 paper from Mikkael A. Sekeres MD, MS Hagop Kantarjian,MD and Dr Estey and contradicts newer reports from Europe. Is it all about power or is there more to the story? UPMC Hematology & Oncology Fellowship Program UPMC Hillman Cancer Center

Had an unforgettable week in #Vail at the ASCO AACR #MCCR22 workshop. Learned so much from inspiring experts in the field and incredible peers!

It’s #NationalDogsDay. Nothing brings joy to my heart like this one

Important/timely paper in Journal of Clinical Oncology Oncology Practice calling out challenges #IMGs face during their road to Academia. ⁦Kudos to the team (including Ariela Marshall MD Penn Medicine - Abramson Cancer Center & Alfred Lee Yale Cancer Center) IMG Oncologists OncoAlert Oncology Brothers A must read! ascopubs.org/doi/abs/10.120…

Our model is out and we will be soon be submitting it to Addgene!

While severe CRS is now less common with #CART, HLH-like syndrome, now termed IEC-HS, remains challenging to manage. Honored to be part of the group for ASTCT guideline. Special shout-out to Nirali Shah to lead the panel to navigate this complex topic! tinyurl.com/4y523h69

Grateful for Dr. Ito’s mentorship through this project. Thanks to #ASH for giving us the opportunity to present our work!

FDA grants accelerated approval to epcoritamab-bysp for relapsed or refractory diffuse large B-cell lymphoma and high-grade B-cell lymphoma. fda.gov/drugs/drug-app…

CAR-T in SCNSL (final data from Matthew Frigault et al. #ASH23 that we've all been citing): - 113 pts, 76% active CNS dx - worse PFS/OS if active CNS (mPFS 2.9 mos) - ↑ PFS with liso-cel in MV model We have been trying to get into CNS CR before CAR-T. #lymsm onlinelibrary.wiley.com/doi/10.1002/aj…

Health system in #Yemen. Only 2 in 5 health facilities can provide injury care and basic laboratory services.

The increased numbers of cholera cases in #Yemen spark concerns of a significant outbreak. Read WHO situation report goo.gl/4RVSYi

20 million people in South Sudan, Somalia, Nigeria & Yemen are #FacingFamine. Please share and help here: ow.ly/jlYD30aKZYc via World Food Programme

This is the fastest growing refugee crisis in the world right now. amn.st/601980vqJ #RohingyaCrisis